Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes

Cardiovascular Research

Volumn 65, Issue 4, 2005, Pages 832-841

  Planavila, Anna ^a   Rodríguez Calvo, Ricardo ^a   Jové, Mireia ^a   Michalik, Liliane ^b   Wahli, Walter ^b   Laguna, Juan C ^a   Vázquez Carrera, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cardiac hypertrophy; L 165041; NF B; p65

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; ATRIAL NATRIURETIC FACTOR; CARNITINE PALMITOYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHENYLEPHRINE; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE KINASE 4; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL SIZE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOPRECIPITATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT;

ACETIC ACIDS; ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; LIGANDS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MYOCYTES, CARDIAC; NF-KAPPA B; PHENOLS; PHENYLEPHRINE; PPAR DELTA; PPAR-BETA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 13844256366     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.11.011     Document Type: Article

References (39)

1. D. Levy, R.J. Garrison, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham Heart-Study N. Engl. J. Med. 322 1990 1561 1566
2. B.H. Lorell, and B.A. Carabello Left ventricular hypertrophy- pathogenesis, detection, and prognosis Circulation 102 2000 470 479
3. N.H. Purcell, G.L. Tang, C.F. Yu, F. Mercurio, J.A. DiDonato, and A.N. Lin Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes Proc. Natl. Acad. Sci. U. S. A. 98 2001 6668 6673
4. S. Hirotani, K. Otsu, K. Nishida, Y. Higuchi, T. Morita, and H. Nakayama Involvement of nuclear factor-kappa B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy Circulation 105 2002 509 515
5. Y. Higuchi, K. Otsu, K. Nishida, S. Hirotani, H. Nakayama, and O. Yamaguchi Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy J. Mol. Cell. Cardiol. 34 2002 233 240
6. S. Gupta, N.H. Purcell, A.N. Lin, and S. Sen Activation of nuclear factor-kappa B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol. 159 2002 1019 1028
7. H. Taegtmeyer, and M.L. Overturf Effects of moderate hypertension on cardiac-function and metabolism in the rabbit Hypertension 11 1988 416 426
8. M.N. Sack, T.A. Rader, S.H. Park, J. Bastin, S.A. Mccune, and D.P. Kelly Fatty acid oxidation enzyme gene expression is downregulated in the failing heart Circulation 94 1996 2837 2842
9. D.P. Kelly, and A.W. Strauss Mechanisms of disease-inherited cardiomyopathies N. Engl. J. Med. 330 1994 913 919
10. B. Binas, H. Danneberg, J. McWhir, L. Mullins, and A.J. Clark Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization FASEB J. 13 1999 805 812
11. H.C. Chiu, A. Kovacs, D.A. Ford, F.F. Hsu, R. Garcia, and P. Herrero A novel mouse model of lipotoxic cardiomyopathy J. Clin. Invest. 107 2001 813 822
12. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
13. J. Auwerx, E. Baulieu, M. Beato, M. Becker-Andre, P.H. Burbach, and G. Camerino A unified nomenclature system for the nuclear receptor superfamily Cell 97 1999 161 163
14. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366
15. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev. Immunol. 2 2002 748 759
16. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappa B and AP-1 J. Biol. Chem. 274 1999 32048 32054
17. F.Q. Liang, F. Wang, S.M. Zhang, and D.G. Gardner Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes Endocrinology 144 2003 4187 4194
18. Y. Irukayama-Tomobe, T. Miyauchi, S. Sakai, Y. Kasuya, T. Ogata, and M. Takanashi Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway Circulation 109 2004 904 910
19. K. Yamamoto, R. Ohki, R.T. Lee, U. Ikeda, and K. Shimada Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes Circulation 104 2001 1670 1675
20. M. Asakawa, H. Takano, T. Nagai, H. Uozumi, H. Hasegawa, and N. Kubota Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246
21. A.J. Gilde, K.A.J.M. van der Lee, P.H.M. Willemsen, G. Chinetti, F.R. van der Leij, and G.J. van der Vusse Peroxisome proliferator-activated receptor (PPAR) alpha and PPAR beta/delta, but not PPAR gamma, modulate the expression of genes involved in cardiac lipid metabolism Circ. Res. 92 2003 518 524
22. J. Berger, M.D. Leibowitz, T.W. Doebber, A. Elbrecht, B. Zhang, and G.C. Zhou Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPAR delta ligands produce distinct biological effects J. Biol. Chem. 274 1999 6718 6725
23. Y. Kimura, K. Otsu, K. Nishida, T. Kuzuya, and M. Tada Thyroid-hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic-reticulum by increasing Ca2+ Atpase and decreasing phospholamban expression J. Mol. Cell. Cardiol. 26 1994 1145 1154
24. C.M. Thaik, A. Calderone, N. Takahashi, and W.S. Colucci Interleukin-1-beta modulates the growth and phenotype of neonatal rat cardiac myocytes J. Clin. Invest. 96 1995 1093 1099
25. A. Cabrero, M. Alegret, R.M. Sanchez, T. Adzet, J.C. Laguna, and M. Vázquez-Carrera Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells J. Biol. Chem. 277 2002 10100 10107
26. M. Takemoto, K. Node, H. Nakagami, Y.L. Liao, M. Grimm, and Y. Takemoto Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy J. Clin. Invest. 108 2001 1429 1437
27. J.D. McGarry, and N.F. Brown The mitochondrial carnitine palmitoyltransferase system-from concept to molecular analysis Eur. J. Biochem. 244 1997 1 14
28. P.F. Wu, J. Sato, Y. Zhao, J. Jaskiewicz, K.M. Popov, and R.A. Harris Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart Biochem. J. 329 1998 197 201
29. J.M. Li, N.P. Gall, D.J. Grieve, M.Y. Chen, and A.M. Shah Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 2002 477 484
30. J. Sadoshima, L. Jahn, T. Takahashi, T.J. Kulik, and S. Izumo Molecular characterization of the stretch-induced adaptation of cultured cardiac-cells-an invitro model of load-induced cardiac-hypertrophy J. Biol. Chem. 267 1992 10551 10560
31. W.S. Shin, A. Szuba, and S.G. Rockson The role of chemokines in human cardiovascular pathology: enhanced biological insights Atherosclerosis 160 2002 91 102
32. H. Takano, T. Nagai, M. Asakawa, T. Toyozaki, T. Oka, and I. Komuro Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced turner necrosis factor-alpha expression in neonatal rat cardiac myocytes Circ. Res. 87 2000 596 602
33. P. Delerive, P. Gervois, J.C. Fruchart, and B. Staels Induction of I kappa B alpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators J. Biol. Chem. 275 2000 36703 36707
34. P. Delerive, K. De Bosscher, W. Vanden Berghe, J.C. Fruchart, G. Haegeman, and B. Staels DNA binding-independent induction of I kappa B alpha gene transcription by PPAR alpha Mol. Endocrinol. 16 2002 1029 1039
35. D.M. Muoio, P.S. MacLean, D.B. Lang, S. Li, J.A. Houmard, and J.M. Way Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice-evidence for compensatory regulation by PPAR delta J. Biol. Chem. 277 2002 26089 26097
36. Y. Jamshidi, H.E. Montgomery, H.W. Hense, S.G. Myerson, I.P. Torra, and B. Staels Peroxisome proliferator-activated receptor a gene regulates left ventricular growth in response to exercise and hypertension Circulation 105 2002 950 955
37. V.P.M. van Empel, and L.J. De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc. Res. 63 2004 487 499
38. T. Shioi, A. Matsumori, Y. Kihara, M. Inoko, K. Ono, and Y. Iwanaga Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload Circ. Res. 81 1997 664 671
39. S. Hayashidani, H. Tsutsui, T. Shiomi, M. Ikeuchi, H. Matsusaka, and N. Suematsu Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 108 2003 2134 2140